BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sergiacomi G, Taglieri A, Chiaravalloti A, Calabria E, Arduini S, Tosti D, Citraro D, Pezzuto G, Puxeddu E, Simonetti G. Acute COPD exacerbation: 3 T MRI evaluation of pulmonary regional perfusion – Preliminary experience. Respiratory Medicine 2014;108:875-82. [DOI: 10.1016/j.rmed.2014.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoffman EA, Lynch DA, Barr RG, van Beek EJ, Parraga G; IWPFI Investigators. Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes. J Magn Reson Imaging 2016;43:544-57. [PMID: 26199216 DOI: 10.1002/jmri.25010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
2 Kaireit TF, Voskrebenzev A, Gutberlet M, Freise J, Jobst B, Kauczor H, Welte T, Wacker F, Vogel‐claussen J. Comparison of quantitative regional perfusion‐weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium‐enhanced regional pulmonary perfusion MRI in COPD patients. J Magn Reson Imaging 2018;49:1122-32. [DOI: 10.1002/jmri.26342] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
3 Rangelov BA, Young AL, Jacob J, Cahn AP, Lee S, Wilson FJ, Hawkes DJ, Hurst JR. Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review. Int J Chron Obstruct Pulmon Dis 2020;15:1751-87. [PMID: 32801677 DOI: 10.2147/COPD.S250746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Aziz M, Krishnam M, Madhuranthakam AJ, Rajiah P. Update on MR imaging of the pulmonary vasculature. Int J Cardiovasc Imaging 2019;35:1483-97. [PMID: 31030315 DOI: 10.1007/s10554-019-01603-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Hatabu H, Ohno Y, Gefter WB, Parraga G, Madore B, Lee KS, Altes TA, Lynch DA, Mayo JR, Seo JB, Wild JM, van Beek EJR, Schiebler ML, Kauczor HU; Fleischner Society. Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper. Radiology 2020;297:286-301. [PMID: 32870136 DOI: 10.1148/radiol.2020201138] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
6 Bell LC, Wang K, Munoz Del Rio A, Grist TM, Fain SB, Nagle SK. Comparison of models and contrast agents for improved signal and signal linearity in dynamic contrast-enhanced pulmonary magnetic resonance imaging. Invest Radiol 2015;50:174-8. [PMID: 25501016 DOI: 10.1097/RLI.0000000000000122] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]